As global markets recover from the corona pandemic the chemical company Indorama Ventures Public Co. Ltd. (IVL), Bangkok/Thailand, reported consolidated revenue of US$ 3.56 billion, an increase of 52% year-on-year in the 2nd quarter (Q2) 2021. EBITDA was $552 million. All 3 business segments, Combined PET, Fibers, and Integrated Oxides & Derivatives (IOD), experience strong demand and margins. Demand for the products remained robust across all segments and all regions.
Higher margins along the portfolio were achieved, leveraging on the integrated operating model and regional supply chain advantage offsetting headwinds in the ecosystem such as shortages of key raw materials and logistics constraints. In an environment of major disruption, IVL’s management has demonstrated agility in responsibly.